ESR1-mutated

Recent news mentioning ESR1-mutated

• 2026-09-18 — U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
• 2026-08-13 — Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

Appears alongside

• FDA
• Inluriyo
• Verzenio
• HER2

Browse the full archive →